These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box. Sgouros G; Frey E; Du Y; Hobbs R; Bolch W Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):18-29. PubMed ID: 34782911 [TBL] [Abstract][Full Text] [Related]
11. Auger radiation targeted into DNA: a therapy perspective. Buchegger F; Perillo-Adamer F; Dupertuis YM; Delaloye AB Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1352-63. PubMed ID: 16896663 [TBL] [Abstract][Full Text] [Related]
12. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution. Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220 [TBL] [Abstract][Full Text] [Related]
13. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings. Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic radionuclides: production and decay property considerations. Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628 [TBL] [Abstract][Full Text] [Related]
15. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy. Lee D; Li M; Bednarz B; Schultz MK Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461 [TBL] [Abstract][Full Text] [Related]
16. Targeted Radionuclide Therapy in Glioblastoma. Zhao X; Jakobsson V; Tao Y; Zhao T; Wang J; Khong PL; Chen X; Zhang J ACS Appl Mater Interfaces; 2024 Aug; 16(31):40391-40410. PubMed ID: 39042829 [TBL] [Abstract][Full Text] [Related]
17. Ultrasmall Gold Nanoparticles Radiolabeled with Iodine-125 as Potential New Radiopharmaceutical. Wang R; Liu H; Antal B; Wolterbeek HT; Denkova AG ACS Appl Bio Mater; 2024 Feb; 7(2):1240-1249. PubMed ID: 38323544 [TBL] [Abstract][Full Text] [Related]
18. Alpha Particle-Emitting Radiopharmaceuticals as Cancer Therapy: Biological Basis, Current Status, and Future Outlook for Therapeutics Discovery. Coll RP; Bright SJ; Martinus DKJ; Georgiou DK; Sawakuchi GO; Manning HC Mol Imaging Biol; 2023 Dec; 25(6):991-1019. PubMed ID: 37845582 [TBL] [Abstract][Full Text] [Related]
19. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons. Aghevlian S; Boyle AJ; Reilly RM Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852 [TBL] [Abstract][Full Text] [Related]
20. Radionuclide-based theranostics - a promising strategy for lung cancer. Zhu T; Hsu JC; Guo J; Chen W; Cai W; Wang K Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2353-2374. PubMed ID: 36929181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]